Why Publish in GENETICS & G3?
Streamlined submission, fast decisions
No more reformatting! We welcome initial submissions in any format and impose no limits on length, figures, or supplemental information. Has your manuscript been reviewed at another journal? Let us know, then provide a response to reviewers; editors can use this in their decision-making process. We can even fast-track handling in some circumstances.
Time to first decision? About a month.
Around a week after initial submission, the editors will let you know whether the manuscript will be sent for review. For reviewed manuscripts, the editors reach a decision in an average of 35 days from your initial submission. More than 90% of revised papers are accepted without an additional round of reviews.
Average time from submission to acceptance is less than 10 weeks.
High-quality review, helpful editors.
Ever struggled with confusing reviews or an unclear decision letter that doesn’t give you a clue about where to start your revision? Our journals are known for their insightful and helpful review processes.
At least two editors consult on every decision.
Your manuscripts will be handled by practicing scientists—like you—who understand from experience what it takes to tell a significant story, create a useful method, or extract meaning from large datasets. Rather than simply tallying reviewer “votes,” your editors synthesize the reviews into a clear decision letter that offers guidance and explains rationales for all decisions, helping to improve your paper’s impact. Still have questions? Contact the editorial office or the editor. Speak with a real person who’ll be up front with you.
Receive consolidated, clear feedback from your editor. including specific guidance for revisions.
Sister journals, one-touch transfer.
If you submit a manuscript to GENETICS that reports high-quality, useful findings but lacks the broad appeal, significance, or novelty of a GENETICS article, you may be offered a transfer to G3. This seamless process can guarantee review at G3 or allow G3 editors to use the GENETICS reviews to offer a decision within days.
Fast access, broad visibility.
Within days, accepted manuscripts are published Early Online, indexed in PubMed, and available to colleagues. You may be selected for highlights in GENETICS, a featured article in G3, cover art, press releases, promotion on GSA’s Genes to Genomes blog, social media, GSA newsletter, and other outreach. We enhance discovery and use of your research, helping increase its impact.
Support your field by publishing with us. GSA is a non-profit society run by and for scientists to advocate for science, bring us together, and foster our work. We are a founding member of the Scientific Society Publishing Alliance, a group of high-quality, peer-reviewed society journals that answer directly to the research community.
As mission-driven publishers, we place a high priority on responding to community needs. We’ve long supported the use of preprints; for example, we were the first journal to partner with Cold Spring Harbor Laboratory to enable seamless deposits of manuscripts from our submission systems to bioRxiv and vice versa. Articles feature links to model organism databases like SGD, FlyBase, WormBase, and FungiDB. Through Overleaf, we provide custom templates for authors who use LaTeX, saving them time at submission. Our partnership with Publons helps you get credit for the reviewing you do at the GSA Journals.
Commitment to data availability.
Our data policy, instituted in 2010, requires all primary data and source code associated with the paper’s findings to be publicly available. Besides providing everything needed for replication, this policy allows your research to have the greatest possible impact and ensures your findings will be used for years to come. We’ve partnered with the data repository figshare to ensure you get credit for all of your work; your supplemental material and data files now get a DOI and are permanently linked to your manuscript.
Not sure if your work is a good fit?
GENETICS welcomes pre-submission inquiries!
Got mutant screen data, whole-genome sequences, or software reports?
G3 has an article type for that.